Case Study
Maximizing agency value in life sciences through strategic AOR selection
A leading biotech firm specializing in rare diseases needed to enhance its commercialization efforts by selecting a new Agency of Record (AOR). The firm sought a partner that could improve brand visibility, refine market positioning, and deliver cost-effective solutions tailored to the rare disease sector.
The current AOR was underperforming, leading to rising costs and inadequate service quality. The firm required a more agile and efficient agency capable of scaling with their growth and addressing the specific challenges of rare disease marketing.
Leveraging our expertise in AOR selection, we executed a streamlined process that included:
Comprehensive RFP management: Directed the entire RFP process, from developing evaluation criteria to making the final selection, ensuring that all client needs were addressed.
Cost negotiation: Achieved a 10% cost saving by negotiating additional services without raising the overall budget.
Right-sized agency fitting: Matched the client with an agency experienced in rare disease marketing, aligning perfectly with their specific requirements.
Accelerated turnaround by finalizing the RFP process within 8 weeks, enabling a smooth transition to the new agency.
Enhanced outcomes, with the new agency significantly improving brand position and market engagement while providing considerable cost savings over the life of the contract.
Our strategic approach to selecting a new AOR enabled the client to achieve their commercialization goals more effectively and efficiently, demonstrating our proficiency in procurement advisory for the life sciences sector.
